Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thiago Carvalho

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Nature Medicine|April 26, 2020
COVID-19 Research in Brief: 18 April to 24 April, 2020Thiago Carvalho
Nature Medicine|May 3, 2020
COVID-19 Research in Brief: 24 April to 1 May, 2020Thiago Carvalho
Nature Medicine|September 1, 2022
mRNA vaccines boost BioNTech's CAR T cell therapyThiago Carvalho
Nature Medicine|July 5, 2023
Anti-CD40L antibody frexalimab slows new brain lesions in multiple sclerosisThiago Carvalho
Nature Medicine|November 30, 2022
A new class of antibiotics delivers promising trial results against tuberculosisThiago Carvalho
Nature Medicine|December 8, 2020
New year, new outbreakThiago Carvalho
Nature Medicine|December 8, 2020
COVID-19 clustersThiago Carvalho
Nature Medicine|December 8, 2020
Vaccines in the fast laneThiago Carvalho
Nature Medicine|April 11, 2023
New depression drug zuranolone one step closer to FDA rulingThiago Carvalho
Nature Medicine|April 5, 2020
COVID-19 Research in Brief: 28 March to 3 April, 2020Thiago Carvalho
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Nature Medicine|April 26, 2020
COVID-19 Research in Brief: 18 April to 24 April, 2020Thiago Carvalho
Nature Medicine|May 3, 2020
COVID-19 Research in Brief: 24 April to 1 May, 2020Thiago Carvalho
Nature Medicine|September 1, 2022
mRNA vaccines boost BioNTech's CAR T cell therapyThiago Carvalho
Nature Medicine|July 5, 2023
Anti-CD40L antibody frexalimab slows new brain lesions in multiple sclerosisThiago Carvalho
Nature Medicine|November 30, 2022
A new class of antibiotics delivers promising trial results against tuberculosisThiago Carvalho
Nature Medicine|December 8, 2020
New year, new outbreakThiago Carvalho
Nature Medicine|December 8, 2020
COVID-19 clustersThiago Carvalho
Nature Medicine|December 8, 2020
Vaccines in the fast laneThiago Carvalho
Nature Medicine|April 11, 2023
New depression drug zuranolone one step closer to FDA rulingThiago Carvalho
Nature Medicine|April 5, 2020
COVID-19 Research in Brief: 28 March to 3 April, 2020Thiago Carvalho
Pageof 9